My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}

Want to join the conversation?

$PSX {{ '2015-10-30T16:45:00+0000' | timeago}} • Webcast

$PSX's 3Q15 Marketing and Specialties segment earnings of $344MM, up from $259MM reported in the comparable quarter last year. Driven by higher global marketing margins, record marketing volumes and continued strong margins in lubricants business. The 2015 annualized YTD adjusted ROCE for M&S was 33% on an average capital employed of $2.9Bil.

User Frankie Joe {{ '2017-02-28T13:37:27+0000' | timeago}}

Samsung's not looking good! South Korea will indict their top boss-to-be Lee Jae-yong for corruption.

User Ashton Alloway {{ '2017-02-28T12:20:18+0000' | timeago}}

$TWTR mentions Snap as one of its fiercest rivals in its 10K filing. Great head start for Snap ahead of IPO!

User Johney Kingston {{ '2017-02-27T20:48:18+0000' | timeago}}

$WMT has indeed intensified the grocery price competition..Watch out $KR and Aldi.

User Felix Nilsson {{ '2017-02-27T20:41:52+0000' | timeago}}

The increasing US oil output seems to offset the bets raised by investors a week ago on increasing Brent crude oil prices.

User Nick Velez {{ '2017-02-27T20:22:11+0000' | timeago}}

Treasury yields moved higher on Monday as investors were cautious to make big government bonds investments ahead of President Donald Trump's first congressional address.

$ESV {{ '2017-02-28T14:20:31+0000' | timeago}} • Announcement

Offshore drilling company $ESV reported 4Q16 net income of $39MM, or $0.13 per share, compared to net loss of $2.47Bil, or $10.64 per share during 4Q15. Revenues declined 39% YoY to $505MM, mainly due to decline in reported utilization to 51%.

$PRGO {{ '2017-02-28T14:18:53+0000' | timeago}} • Announcement

$PRGO agreed to divest its rights to the royalty stream from the global net sales of the multiple sclerosis drug Tysabri (natalizumab) to RPI Finance Trust, an affiliate of Royalty Pharma. This transaction is valued at a total consideration of up to $2.85Bil. This transaction is expected to close within 30 business days.

$EBIX {{ '2017-02-28T14:07:43+0000' | timeago}} • Announcement

Software and e-commerce services supplier $EBIX reported 12% increase in its 4Q16 earnings to $24.6MM, compared to $21.9MM during 4Q15. Diluted EPS rose 17% YoY to $0.76 from $0.65 in 4Q15. Revenues rose 14% YoY $80MM.

$ENDP {{ '2017-02-28T14:00:48+0000' | timeago}} • Webcast

$ENDP, which divested its Belbuca business and restructured Pain franchise business in 4Q16, announced its plans to divest Litha Healthcare Group business for $100MM to Acino. The company has also identified Somar business as non-core and will be conducting due diligence on divesting Somar to focus on regulated markets in developed countries.

$VRX {{ '2017-02-28T14:00:42+0000' | timeago}} • Webcast

$VRX said it is looking for low single digit growth in GI business in 2017, before moving to high single digit growth in 2018 and beyond. Additionally, the diversified segment, which is projected to decline 7-10% in 2017 vs. 2016, is expected to still face above average declines in 2018.